X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pegfilgrastim (494) 494
humans (445) 445
filgrastim (378) 378
index medicus (356) 356
oncology (347) 347
chemotherapy (333) 333
female (289) 289
colony-stimulating factor (267) 267
febrile neutropenia (263) 263
neutropenia (246) 246
middle aged (244) 244
single-administration pegfilgrastim (235) 235
polyethylene glycols (227) 227
aged (211) 211
male (210) 210
cancer (202) 202
daily filgrastim (199) 199
granulocyte colony-stimulating factor (195) 195
granulocyte colony-stimulating factor - therapeutic use (195) 195
adult (191) 191
breast-cancer (162) 162
recombinant proteins (160) 160
g-csf (156) 156
multicenter (143) 143
granulocyte colony-stimulating factor - administration & dosage (141) 141
neutropenia - chemically induced (138) 138
breast cancer (119) 119
hematology (117) 117
double-blind (110) 110
neutropenia - drug therapy (110) 110
neutropenia - prevention & control (108) 108
non-hodgkins-lymphoma (107) 107
antineoplastic combined chemotherapy protocols - adverse effects (105) 105
breast neoplasms - drug therapy (104) 104
pharmacology & pharmacy (100) 100
antineoplastic agents - adverse effects (99) 99
treatment outcome (98) 98
medicine & public health (90) 90
granulocyte colony-stimulating factor - adverse effects (87) 87
neoplasms - drug therapy (80) 80
antineoplastic combined chemotherapy protocols - therapeutic use (79) 79
phase-iii (78) 78
retrospective studies (78) 78
care and treatment (74) 74
health care sciences & services (71) 71
chemotherapy-induced neutropenia (69) 69
recombinant proteins - therapeutic use (68) 68
research (64) 64
risk factors (64) 64
cell lung-cancer (60) 60
transplantation (60) 60
antineoplastic combined chemotherapy protocols - administration & dosage (58) 58
drug administration schedule (57) 57
recombinant proteins - administration & dosage (57) 57
young adult (55) 55
induced febrile neutropenia (54) 54
cyclophosphamide (53) 53
dose-response relationship, drug (53) 53
drug therapy (52) 52
aged, 80 and over (50) 50
analysis (50) 50
nursing (48) 48
risk (48) 48
adjuvant chemotherapy (47) 47
rehabilitation (46) 46
animals (45) 45
antineoplastic agents - therapeutic use (44) 44
docetaxel (44) 44
dose-intensity (44) 44
lymphoma (44) 44
prophylaxis (44) 44
cycle (43) 43
growth-factors (43) 43
health aspects (43) 43
cyclophosphamide - administration & dosage (42) 42
medicine, general & internal (42) 42
elderly-patients (41) 41
hematology, oncology and palliative medicine (41) 41
lymphomas (41) 41
primary prophylaxis (40) 40
colony-stimulating factors (39) 39
prospective studies (39) 39
granulocyte colony-stimulating factor - pharmacology (38) 38
guidelines (38) 38
recombinant proteins - adverse effects (38) 38
adolescent (37) 37
cancer patients (37) 37
filgrastim - therapeutic use (37) 37
granulocytes (37) 37
neutrophils (37) 37
patients receiving chemotherapy (37) 37
randomized-trial (37) 37
granulocyte colony-stimulating factor - pharmacokinetics (36) 36
original (36) 36
safety (36) 36
doxorubicin (35) 35
doxorubicin - administration & dosage (35) 35
macrophage colony stimulating factor (35) 35
pain medicine (35) 35
polyethylene glycols - administration & dosage (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (630) 630
French (10) 10
Spanish (9) 9
Czech (5) 5
German (5) 5
Japanese (5) 5
Polish (5) 5
Russian (4) 4
Portuguese (2) 2
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 313 - 313
313 Background: Docetaxel (D) chemotherapy is a standard of care in men with advanced prostate cancer (APC), both metastatic castration sensitive (CS) and... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, Issue 1, pp. 8 - 32
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 12/2018, Volume 45, Issue 12, pp. 1729 - 1732
Febrile neutropenia(FN)is a frequent adverse event observed in cancer patients undergoing chemotherapy that may cause life-threatening infections. However,... 
Pegfilgrastim | Breast cancer chemotherapy
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2006, Volume 42, Issue 15, pp. 2433 - 2453
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 11/2017, Volume 25, Issue 11, pp. 3295 - 3304
Journal Article
Polymer Chemistry, ISSN 1759-9954, 07/2011, Volume 2, Issue 7, pp. 1442 - 1448
PEGylation or covalent attachment of poly(ethylene glycol) improves the pharmacokinetic properties of protein drugs. In vivo circulation lifetimes are... 
COVALENT ATTACHMENT | POLYMER SCIENCE | CERTOLIZUMAB PEGOL CDP870 | ADENOSINE-DEAMINASE | IN-SITU GROWTH | PEGINTERFERON ALPHA-2A | SINGLE-ADMINISTRATION PEGFILGRASTIM | CHRONIC HEPATITIS-C | RADICAL POLYMERIZATION | POLYETHYLENE-GLYCOL | HORMONE-RECEPTOR ANTAGONIST
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 09/2007, Volume 23, Issue 9, pp. 2283 - 2295
Journal Article